| |
|
| |
ThromboGenics is a leading biopharmaceutical company focused on the discovery and development of novel therapeutics
for diseases related to... more » |
|
|
|
|
 |
|
| |
ThromboGenics has developed a strong pipeline of products for the treatment of a broad range of conditions related to the vasculature, including visual disorders, ... more » |
|
|
|
|
|
|
| |
September 6, 2010
ThromboGenics presents positive pooled results from the MIVI-TRUST Phase III program, confirming Microplasmin's potential to transform the treatment of retinal disorders.. more »
ThromboGenics presenteert positieve resultaten van de gecombineerde analyse van het MIVI-TRUST fase III programma die het potentieel van Microplasmine bevestigen om de behandeling van retinale aandoeningen aanzienlijk te wijzigen.. meer »
|
|
|
|
All rights reserved © ThromboGenics 2006